Benzinga | Feb 9, 2021 04:06PM EST

Deciphera Pharmaceuticals Q4 EPS $(1.10) Beats $(1.15) Estimate, Sales $19.49M Beat $18.93M Estimate

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.10) per share which beat the analyst consensus estimate of $(1.15) by 4.35 percent. This is a 16.03 percent increase over losses of $(1.31) per share from the same period last year. The company reported quarterly sales of $19.49 million which beat the analyst consensus estimate of $18.93 million by 2.94 percent.